Lantern Pharma Inc
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| – | +218.5% | +1,321.2% | +263.2% | -20.4% | -25.8% | -41.4% | -56.8% | |
| – | +176.9% | +1,541.5% | +259.3% | -19.2% | -26.2% | -41.7% | -57.2% | |
| – | +176.8% | +1,460.8% | +167.9% | -27.8% | -41.0% | -65.8% | -41.1% | |
| – | +176.8% | +1,460.8% | +267.8% | -22.0% | -25.2% | -41.9% | -57.9% | |
| – | – | – | – | +227.1% | +45.3% | -88.7% | -69.1% | |
| – | – | – | – | – | – | – | – | |
| – | +87.6% | +145.6% | +905.2% | -77.8% | – | – | – | |
| – | -24.9% | +35.1% | +260.0% | +17.6% | -2.1% | +60.0% | +2.7% | |
| – | -24.9% | +12.9% | +321.1% | +20.3% | -4.3% | +61.7% | +3.9% | |
| – | – | – | – | -65.2% | +227.0% | +10.3% | +41,060.0% | |
| – | +389.9% | -9.6% | +402.9% | -57.1% | +1.1% | +339.4% | +6.8% | |
| – | – | – | – | – | – | – | – | |
| – | – | +1,988.3% | +263.3% | -21.7% | -27.0% | -48.2% | -69.2% | |
| – | – | – | – | – | – | – | – | |
| – | +0.8% | -0.7% | +75.3% | -0.5% | -0.1% | -0.7% | +1.3% |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.